These are definitely exciting and hopeful times for Rett community. Taysha Gene Therapies have announced that the first patient was dosed with the investigational gene therapy, TSHA-102, in the REVEAL Adult Study, a clinical trial for females 18 years and older living with Rett syndrome.
As things move forward, we´d like to share the letter Taysha Patient Affairs team developed to share this news with the community and answer some frequently asked questions.
Taysha administered the first dose of investigational gene therapy drug